Thrombosis
Video
DOAC pause yields favorable outcomes for AF patients
SAN DIEGO – Results from the PAUSE study could set the standard for timing of perioperative DOAC interruption.
Video
ARISTOPHANES: Apixaban edges other DOACS for octogenarians
CHICAGO – Insurance claims data from more than 50,000 U.S. octogenarians on a DOAC showed apixaban worked best and caused the fewest major bleeds...
News
ASH releases new VTE guidelines
A panel of the American Society of Hematology released more than 150 recommendations for dealing with venous thromboembolism.
News
All patients with VTE have a high risk of recurrence
Researchers suggest rethinking categorization of patients with incident venous thromboembolism.
News
Apixaban is safest effective DOAC for stroke prevention in Afib, per AHRQ report
The agency found the lowest bleeding risk with apixaban, but cites lack of head-to-head trials as a limitation in evaluating DOACs.
News
CT opens extended window for stroke thrombolysis
MONTREAL – The new EXTEND findings “will have a major impact” on using an extended time window for thrombolysis in U.S. practice.
Article
EHR-guided strategy reduces postop VTE events
BOSTON – Missed doses of enoxaparin correlate with increased incidence of deep vein thrombosis.
News
VTE risk after gynecologic surgery lower with laparoscopic procedures
Laparoscopic and vaginal gynecologic surgery are associated with a lower incidence of postoperative VTE, compared with laparotomy.
News
Stroke risk in elderly following AMI extends to 12 weeks
ATLANTA – The prolonged period of heightened risk was evident in patients with both STEMI and NSTEMI.
News
Readmission to non-index hospital following acute stroke linked to worse outcomes
ATLANTA – Study adds to the stroke literature on nationwide estimates of 30-day readmissions.